van den Bos RR - Search Results

1

Long-term outcomes, quality of life, and costs of treatment modalities for T1-T2 lip carcinomas.

van Hof KS, Wakkee M, Sewnaik A, Herkendaal AF, Tans L, Mast H, van den Bos RR, Mureau MAM, Offerman MPJ, Baatenburg de Jong RJ. van Hof KS, et al. Among authors: van den bos rr. Oral Dis. 2023 Aug 31. doi: 10.1111/odi.14723. Online ahead of print. Oral Dis. 2023. PMID: 37650356

2

[Micrographic surgery of lentigo maligna].

van den Bos RR, Wakkee M, Koljenovil S, Nijsten T. van den Bos RR, et al. Ned Tijdschr Geneeskd. 2016;160:A9827. Ned Tijdschr Geneeskd. 2016. PMID: 27050497 Dutch.

3

Epidemiology of Lentigo Maligna and Lentigo Maligna Melanoma in the Netherlands, 1989-2013.

Greveling K, Wakkee M, Nijsten T, van den Bos RR, Hollestein LM. Greveling K, et al. Among authors: van den bos rr. J Invest Dermatol. 2016 Oct;136(10):1955-1960. doi: 10.1016/j.jid.2016.06.014. Epub 2016 Jun 24. J Invest Dermatol. 2016. PMID: 27349862 Free article.

4

Mohs micrographic surgery of rare cutaneous tumours.

Flohil SC, van Lee CB, Beisenherz J, Mureau MAM, Overbeek LIH, Nijsten T, van den Bos RR. Flohil SC, et al. Among authors: van lee cb, van den bos rr. J Eur Acad Dermatol Venereol. 2017 Aug;31(8):1285-1288. doi: 10.1111/jdv.14079. Epub 2017 Jan 24. J Eur Acad Dermatol Venereol. 2017. PMID: 27976423

5

Recurrence rates of cutaneous squamous cell carcinoma of the head and neck after Mohs micrographic surgery vs. standard excision: a retrospective cohort study.

van Lee CB, Roorda BM, Wakkee M, Voorham Q, Mooyaart AL, de Vijlder HC, Nijsten T, van den Bos RR. van Lee CB, et al. Among authors: van den bos rr. Br J Dermatol. 2019 Aug;181(2):338-343. doi: 10.1111/bjd.17188. Epub 2018 Oct 28. Br J Dermatol. 2019. PMID: 30199574

6

Recurrence of periocular basal cell carcinoma and squamous cell carcinoma after Mohs micrographic surgery: a retrospective cohort study.

Weesie F, Naus NC, Vasilic D, Hollestein LM, van den Bos RR, Wakkee M. Weesie F, et al. Among authors: van den bos rr. Br J Dermatol. 2019 May;180(5):1176-1182. doi: 10.1111/bjd.17516. Epub 2019 Feb 10. Br J Dermatol. 2019. PMID: 30536656 Free PMC article.

7

Substitution of low-risk skin cancer hospital care towards primary care: A qualitative study on views of general practitioners and dermatologists.

Noels EC, Wakkee M, van den Bos RR, Bindels PJE, Nijsten T, Lugtenberg M. Noels EC, et al. Among authors: van den bos rr. PLoS One. 2019 Mar 19;14(3):e0213595. doi: 10.1371/journal.pone.0213595. eCollection 2019. PLoS One. 2019. PMID: 30889211 Free PMC article. Clinical Trial.

8

Dermatofibrosarcoma Protuberans Re-excision and Recurrence Rates in the Netherlands Between 1989 and 2016.

van Lee CB, Kan WC, Gran S, Mooyaart A, Mureau MAM, Williams HC, Matin R, van den Bos R, Hollestein LM. van Lee CB, et al. Acta Derm Venereol. 2019 Nov 1;99(12):1160-1165. doi: 10.2340/00015555-3287. Acta Derm Venereol. 2019. PMID: 31410492 Free article.

9

Increasing Costs of Skin Cancer due to Increasing Incidence and Introduction of Pharmaceuticals, 2007-2017.

Noels E, Hollestein L, Luijkx K, Louwman M, de Uyl-de Groot C, van den Bos R, van der Veldt A, Grünhagen D, Wakkee M. Noels E, et al. Acta Derm Venereol. 2020 May 28;100(10):adv00147. doi: 10.2340/00015555-3463. Acta Derm Venereol. 2020. PMID: 32189004 Free PMC article.

10

Validation of four cutaneous squamous cell carcinoma staging systems using nationwide data.

Venables ZC, Tokez S, Hollestein LM, Mooyaart AL, van den Bos RR, Rous B, Leigh IM, Nijsten T, Wakkee M. Venables ZC, et al. Among authors: van den bos rr. Br J Dermatol. 2022 May;186(5):835-842. doi: 10.1111/bjd.20909. Epub 2022 Mar 26. Br J Dermatol. 2022. PMID: 34862598 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

68 results

Search Page